The present invention provides for MCHR1 antagonist compounds of formula (I) and the pharmaceutically acceptable salts, solvates and prodrugs thereof, wherein the substituents are as defined herein, and the pharmaceutically acceptable salts, solvates and
-
Page/Page column 72
(2010/11/30)
More Articles about upstream products of 1247394-67-7